Replies to post #26466 on CV Sciences Inc (CVSI)

[jefra1965]

I see CVSI as a $14 To $17 stock 2 weeks after uplisting. If not sooner.

[ANIA77]

Yes. FDA approved Epidiolex on June 25 and they have 90 days to get it off schedule 1.. that would be by Sep. 23..

EPIDIOLEX will be marketed in the U.S. by Greenwich Biosciences, the U.S. subsidiary of GW Pharmaceuticals plc. As part of the approval process, EPIDIOLEX must be rescheduled from its current Schedule I before it can be made available to patients. Rescheduling is expected to occur within 90 days.

$CVSI